Posted: 29 March 2022
AusBiotech is proud to launch AusBioNSW, a new peak industry membership body for NSW, to represent, connect, and promote NSW organisations doing business in and with the local, national and global life sciences economy.
The prosperous NSW community of medtech and biotech companies is now supported by a dedicated local body to foster local connection, and ensure it is structurally connected to national and global happenings, and supported to capitalise on growth opportunities and on new technologies.
AusBioNSW is backed by AusBiotech’s national representation on advocacy activities, membership services, events and networks – and for AusBiotech members in NSW, no additional membership subscription is required.
AusBiotech’s CEO Lorraine Chiroiu said, “AusBiotech has been working closely with its NSW members and the NSW Government for many years, and AusBioNSW will take this support to the next level so that the NSW life sciences industry is structurally supported to capitalise on growth opportunities and on new technologies.”
AusBioNSW Chair, Graham McLean, will provide leadership for NSW and its Committee. This support is already being felt, with active meetings and activities to accelerate R&D investment and development in NSW. Graham McLean, Non-Executive Director, Universal Biosensors is a highly-experienced healthcare senior executive leader with extensive service in the medical technology industry in Australia, Asia and US. He has recently returned to Sydney after a successful 16-year career at Stryker, where he was most recently President Asia Pacific, reporting to the global CEO and sitting on Stryker’s global executive leadership team.
Graham McLean said, “I am delighted to support the launch of AusBioNSW a new AusBiotech initiative. NSW has a strong reputation of a thriving biotech and medtech sector, and we plan to accelerate the opportunities for growth, collaboration and job creation with our partners and State government across NSW. As Chair of the NSW Leadership Committee, I look forward to contributing to enhancing AusBiotech’s national capabilities.”
AusBioNSW will promote and showcase local capabilities and facilitate connections and networks. In addition to a strategic workplan, a calendar of events is underway to build relationships, grow skills, and share ideas. This includes:
This year AusBiotech partnered with and profiled NSW Government and leading biotech companies internationally during JP Morgan week 2022; and we’re looking forward to uniting again through AusBiotech’s strong ‘Team Australia’ delegation to BIO 2022.